GeneFo

Company Overview

Snapshot

Founded in September 2014 by Neer Ziskind and Yael Wilnai, GeneFo operated with 1–10 employees. The company ceased operations in June 2019, marking a significant transition for the social medical platform.

Business overview

GeneFo developed a real-time crowdsourcing platform designed to classify and match patients with similar conditions based on genetic alterations. The platform enabled patients to access peer advice, medical feedback from in-house health professionals, personal condition progress reports, and clinical trial matching. Researchers could also utilize the platform to analyze patient-driven data from a phenotypic perspective. GeneFo operated within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement, serving patients globally.

Strategic signal

In March 2018, GeneFo released updated guides to assist patients with specific conditions, including a guide highlighting cystic fibrosis treatment options and guides for fibromyalgia and Parkinson's patients on applying for medical cannabis. These initiatives demonstrated the company's focus on providing targeted information and support to chronic patient communities, aiming to empower users with relevant medical knowledge.

Company Intelligence Q&A

What is GeneFo's primary focus?

GeneFo provides a real-time crowdsourcing platform that classifies and matches patients with the same condition based on genetic alterations, offering peer advice, medical feedback, and clinical trial matching.

When was GeneFo founded and by whom?

GeneFo was founded in September 2014 by co-founders Neer Ziskind and Yael Wilnai.

What was the operational status of GeneFo?

GeneFo is currently non-active, having ceased operations in June 2019.

What kind of resources did GeneFo offer to patients?

GeneFo offered various resources, including free online webinars on topics like humor and laughter as therapy for cystic fibrosis in September 2017, and the effects of natural remedies on multiple sclerosis in October 2016.

How did GeneFo support patients with specific conditions?

In March 2018, GeneFo released guides to help patients, such as an updated guide for cystic fibrosis treatment options and guides for fibromyalgia and Parkinson's patients on applying for medical cannabis.